IEQ Capital’s Strongbridge Biopharma plc. SBBP Stock Holding History

IEQ Capital’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-41,756	Closed	-$85K	–	770
2021 Q3	$85K	Hold	41,756	–	–	﹤0.01%	681
2021 Q2	$124K	Buy	41,756 +20,800	+99%	+$54.9K	﹤0.01%	598
2021 Q1	$58K	Buy	+20,956	New	+$63.2K	﹤0.01%	476
2020 Q4	–	Sell	-20,956	Closed	-$44K	–	415
2020 Q3	$44K	Hold	20,956	–	–	﹤0.01%	387
2020 Q2	$79K	Buy	+20,956	New	+$62.8K	0.01%	311

IEQ Capital's SBBP Position: Q4 2021 in Review

IEQ Capital sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 41,756 shares — an estimated $85K sold.

IEQ Capital first reported a position in SBBP in Q2 2020 and held it in 5 quarters. The position peaked at $124K in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

IEQ Capital reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
IEQ Capital sold 41,756 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $85K.
IEQ Capital first reported a position in Strongbridge Biopharma plc. in Q2 2020 and held it in 5 quarters.
IEQ Capital's Strongbridge Biopharma plc. position peaked at $124K in Q2 2021.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on IEQ Capital's 13F filing for Q4 2021, filed 31 Jan 2022.